Falissard L, Morgand C, Roussel S, Imbaud C, Ghosn W, Bounebache K, et al. A Deep Artificial Neural Network-Based Model for Prediction of Underlying Cause of Death From Death Certificates: Algorithm Development and Validation. JMIR Med Inform. 2020 Apr 28;8(4):e17125.
Laanani M, Imbaud C, Tuppin P, Poulalhon C, Jollant F, Coste J, et al. Contacts with Health Services During the Year Prior to Suicide Death and Prevalent Conditions A Nationwide Study. J Affect Disord. 2020 Sep 1;274:174–82.
de Visme S, Chalumeau M, Levieux K, Patural H, Harrewijn I, Briand-Huchet E, et al. National Variations in Recent Trends of Sudden Unexpected Infant Death Rate in Western Europe. J Pediatr. 2020 Jun 23;
Benhamou D, Lienhart A, Auroy Y, Péquignot F, Jougla E. Accidents by ABO incompatibility and other main complications related to blood transfusion in surgical patients: data from the French national survey on anaesthesia-related deaths. Transfus Clin Biol. 2005 Nov;12(5):389–90.
Lewden C, Salmon D, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005 Feb;34(1):121–30.
Salmon-Ceron D, Lewden C, Morlat P, Bévilacqua S, Jougla E, Bonnet F, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005 Jun;42(6):799–805.
Bonnet F, Lewden C, May T, Heripret L, Jougla E, Bevilacqua S, et al. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis. 2005;37(6–7):482–7.
Fouillet A, Rey G, Jougla E, Frayssinet P, Bessemoulin P, Hémon D. A predictive model relating daily fluctuations in summer temperatures and mortality rates. BMC Public Health. 2007;7:114.
Lavallée PC, Labreuche J, Spieler JF, Jougla E, Amarenco P. Stroke and vascular mortality trends in France: 1979-200Neuroepidemiology. 2007;29(1–2):78–82.
Rey G, Jougla E, Fouillet A, Pavillon G, Bessemoulin P, Frayssinet P, et al. The impact of major heat waves on all-cause and cause-specific mortality in France from 1971 to 2003. Int Arch Occup Environ Health. 2007 Jul;80(7):615–26.
Spallek J, Arnold M, Razum O, Juel K, Rey G, Deboosere P, et al. Cancer mortality patterns among Turkish immigrants in four European countries and in Turkey. Eur J Epidemiol. 2012 Dec;27(12):915–21.
Aouba A, Rey G, Pavillon G, Jougla E, Rothschild C, Torchet MF, et al. Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies. Haemophilia. 2012 May;18(3):339–44.
Encrenaz G, Contrand B, Leffondré K, Queinec R, Aouba A, Jougla E, et al. Impact of the 1998 football World Cup on suicide rates in France: results from the national death registry. Suicide Life Threat Behav. 2012 Apr;42(2):129–35.
Carel JC, Ecosse E, Landier F, Meguellati-Hakkas D, Kaguelidou F, Rey G, et al. Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study. J Clin Endocrinol Metab. 2012 Feb;97(2):416–25.
Vandenheede H, Deboosere P, Stirbu I, Agyemang CO, Harding S, Juel K, et al. Migrant mortality from diabetes mellitus across Europe: the importance of socio-economic change. Eur J Epidemiol. 2012 Feb;27(2):109–17.
Haus-Cheymol R, Boussaud M, Jougla E, Verret C, Decam C, Pommier de Santi V, et al. Mortality among active-duty male French Armed Forces, 2006-10. J Public Health (Oxf). 2012 Aug;34(3):454–61.
Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, Viboud C. Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS ONE. 2012;7(9):e45051.
Boulogne R, Jougla E, Breem Y, Kunst AE, Rey G. Mortality differences between the foreign-born and locally-born population in France (2004-2007). Soc Sci Med. 2012 Apr;74(8):1213–23.
Bhopal RS, Rafnsson SB, Agyemang C, Fagot-Campagna A, Giampaoli S, Hammar N, et al. Mortality from circulatory diseases by specific country of birth across six European countries: test of concept. Eur J Public Health. 2012 Jun;22(3):353–9.
Windenberger F, Rican S, Jougla E, Rey G. Spatiotemporal association between deprivation and mortality: trends in France during the nineties. Eur J Public Health. 2012 Jun;22(3):347–53.
Laribi S, Aouba A, Nikolaou M, Lassus J, Cohen-Solal A, Plaisance P, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012 Mar;14(3):234–9.
Rey G, Jougla E. Are alcohol-attributable mortality estimates reliable? Eur J Public Health. 2014 Feb;24(1):3–4.
Lamarche-Vadel A, Pavillon G, Aouba A, Johansson LA, Meyer L, Jougla E, et al. Automated comparison of last hospital main diagnosis and underlying cause of death ICD10 codes, France, 2008-2009. BMC Med Inform Decis Mak. 2014;14:44.
Morlat P, Roussillon C, Henard S, Salmon D, Bonnet F, Cacoub P, et al. Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000. AIDS. 2014 May 15;28(8):1181–91.
Viallon V, Banerjee O, Jougla E, Rey G, Coste J. Empirical comparison study of approximate methods for structure selection in binary graphical models. Biom J. 2014 Mar;56(2):307–31.
Vuillermoz C, Aouba A, Grout L, Vandentorren S, Tassin F, Vazifeh L, et al. Estimating the number of homeless deaths in France, 2008-2010. BMC Public Health. 2014;14:690.
Saucedo M, Bouvier-Colle MH, Chantry AA, Lamarche-Vadel A, Rey G, Deneux-Tharaux C. Pitfalls of national routine death statistics for maternal mortality study. Paediatr Perinat Epidemiol. 2014 Nov;28(6):479–88.
Lefeuvre D, Pavillon G, Aouba A, Lamarche-Vadel A, Fouillet A, Jougla E, et al. Quality comparison of electronic versus paper death certificates in France, 2010. Popul Health Metr. 2014;12(1):3.
Romon I, Rey G, Mandereau-Bruno L, Weill A, Jougla E, Eschwège E, et al. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort. Diabet Med. 2014 Aug;31(8):946–53.
Westerling R, Westin M, McKee M, Hoffmann R, Plug I, Rey G, et al. The timing of introduction of pharmaceutical innovations in seven European countries. J Eval Clin Pract. 2014 Aug;20(4):301–10.